GlassScriptPhysician profile
Parina Aggarwal
NPI 1346443652
$2,232.61
in general payments reported to CMS, 2019-2025
14 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $236 · 2021: $16.21 · 2022: $261 · 2023: $254 · 2024: $579 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384 · Consulting Fee: $150 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.60 |
| Consulting Fee | $150.00 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $816.42 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $630.66 | 2020-2025 | Wakix |
| Idorsia Pharmaceuticals US INC | $195.76 | 2022-2025 | Quviviq, Quviviq |
| Avadel Cns Pharmaceuticals, LLC | $195.21 | 2024-2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $93.27 | 2019-2024 | |
| Ucb, INC. | $50.81 | 2019-2020 | |
| Resmed Corp | $50.73 | 2023-2024 | |
| Axsome Therapeutics, INC. | $47.10 | 2022-2025 | Sunosi |
| Azurity Pharmaceuticals, INC. | $46.73 | 2024-2025 | Horizant |
| Takeda Pharmaceuticals U.S.A., INC. | $28.61 | 2025 | |
| Arbor Pharmaceuticals, INC. | $24.93 | 2019 | |
| Lilly USA, LLC | $21.42 | 2025 | Zepbound |
| Zoll Respicardia, INC. | $17.41 | 2024 | Remede System |
| Aytu Biopharma, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parina Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.